News & Updates
Showing Endocrinology articles
Showing
Show Multimedia Only

Empagliflozin shows promise for chronic SIAD-induced hyponatremia
26 Jul 2022
byAudrey Abella
The sodium-glucose cotransporter 2 inhibitor empagliflozin showed potential as a treatment alternative for hyponatremia due to chronic syndrome of inadequate antidiuresis (SIAD), according to a trial presented at ENDO 2022.
26 Jul 2022

Obese/overweight patients incur 10 percent long-term weight loss with lifestyle management, medication
25 Jul 2022
byRoshini Claire Anthony
Individuals who are overweight or obese can achieve an approximately 10 percent weight loss over 3–5 years with the use of anti-obesity medications in addition to lifestyle management, according to a retrospective study presented at ENDO 2022.
25 Jul 2022

Lower diabetes risk test cutoff ups lab cost, identifies more persons with prediabetes
24 Jul 2022
Use of the American Diabetes Association (ADA) Diabetes Risk Test (DRT) cutoff score of 4 as part of an employee wellness screening program to identify individuals at risk for developing the disease adds up to laboratory costs, reports a study.
24 Jul 2022






